Related Experiment Video

Updated: May 21, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds

Omar S El-Masry1, Barry L Brown, Pauline R M Dobson

  • 1Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.

Oncology Letters
|June 29, 2012
PubMed

Insights

AMP-activated protein kinase (AMPK) activation shows anti-proliferative effects in breast cancer cells. However, responses vary, suggesting AMPK as a potential target dependent on cancer cell genetics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Breast cancer presents ongoing therapeutic challenges, driving the search for novel drug targets.
  • The AMP-activated protein kinase (AMPK) signaling pathway is recognized for its potential therapeutic intervention in cancer.
  • Understanding AMPK's role in breast cancer is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the effects of AMPK activation on breast cancer cell proliferation, apoptosis, and mitochondrial membrane potential.
  • To evaluate the differential responses of breast cancer cell lines with varying p53 and estrogen receptor (ER) statuses to AMPK activation.
  • To determine the potential of AMPK as a therapeutic target in breast cancer.

Main Methods:

  • Utilized three distinct breast cancer cell lines (MCF-7, MDA-MB-231, T47D) with differing p53 and ER profiles.
  • Activated AMPK using AICAR (5-aminoimidazole carboxamide ribonucleotide) and phenformin.
  • Assessed cell proliferation, apoptosis, cell cycle arrest, and mitochondrial membrane potential.

Main Results:

  • AMPK activation by AICAR and phenformin demonstrated significant anti-proliferative effects across all tested breast cancer cell lines.
  • Differential sensitivity and responses were observed, including cell cycle arrest in T47D cells and apoptosis in MCF-7 and MDA-MB-231 cells.
  • Evidence suggests the involvement of the mitochondrial apoptotic pathway in all cell lines studied.

Conclusions:

  • AMPK activation exhibits anti-proliferative and pro-apoptotic effects in breast cancer cells, indicating its potential as a therapeutic target.
  • The efficacy of AMPK-targeting therapies may be influenced by the specific genetic background of breast cancer cells.
  • Further research into AMPK signaling in diverse breast cancer subtypes is warranted to optimize therapeutic strategies.

More Related Videos

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells08:33

Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells

Published on: April 25, 2014

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...